Objectives: To present the results for subgroups defined by center point (CP) measurement and to assess the repeatability of the Fast Retinal Thickness Map analysis results from the Stratus OCT3 machine.
O
PTICAL COHERENCE TOmography (OCT) was introduced commercially as a new retinal imaging modality in 1995. It has quickly become a standard tool for clinical diagnostic and research purposes for glaucoma and macular diseases. The 10-µm axial resolution of third-generation OCT allows objective measurement of retinal thickness, assessment of retinal morphology, and detection of subretinal fluid. Clinicians and researchers have come to rely on the numeric measurements generated by the manufacturer's scanning software for detection and longitudinal assessment of macular thickening and for clinical research study eligibility and outcomes. Optical coherence tomography is also used for the evaluation of choroidal neovascularization due to age-related macular degeneration (AMD) and other causes. The study of retinal morphology and topography using OCT in exudative AMD is more commonly adjunctive to other assessments, such as fluorescein angiography. Laser light attenuation from OCT scanning deep to the retina renders choroidal features less demonstrable than retinal morphology.
The majority of the current literature reporting OCT measurements in normal and diseased maculas describes first-and second-generation machines. Measurement repeatability of the third-generation device is expected to be improved slightly over earlier versions because of greater rapidity of scan acquisition (which avoids movement artifact) and software enhancements.
We assessed measurement repeatability in the setting of a large series of operator certification submissions to a centralized reading center from multiple clinical sites. These certification submissions consisted of consecutive scans of the same patient at the same visit taken by the same technician using the same equipment. Operators were applying for certification to participate in clinical trials of exudative AMD or macular edema (ME) due to diabetic retinopathy or retinal vascular occlusion.
lines centered at the fovea equally spaced 30°apart with an acquisition time of 0.32 s/line and scan density (A-scans per scan) of 128. The analysis of this scan yields the Fast Macular Thickness Map, consisting of 9 sectoral thickness values in 3 concentric circles with diameters of 1, 3, and 6 mm. The sectoral measurements reported in the map are the average of the 6 linear scans for that sector. The center point (fovea minimum parameter) is the mean of the 6 measurements from the intersection of the scan lines and is reported with its standard deviation.
These certification submissions consisted of replicate scans of the same eye of the same patient at the same visit taken by the same technician using the same equipment. The scans may or may not have been consecutive, since the operator may have discarded suboptimal maps. The submissions included prints of the 6 underlying radial scans from the fast macular algorithm and a seventh print with the retinal thickness map measurements.
Each scan was evaluated by staff at a central reading center for accuracy of boundary delineation by the instrument and for completeness of the submission. Eyes were excluded from analysis if (1) there were boundary line artifacts in more than 1 of the 6 radial scans affecting the outer subfields only, (2) there was a boundary line artifact affecting the center subfield in any scan, or (3) more than 2 scan prints were missing from the submission and there was artifact suggested on the retinal map print. 1 Two "normal" eyes and 2 eyes with the disease under investigation were submitted for certification. The selection of patients was at the discretion of the technician. No other patient data were submitted (eg, history, examination, or visual acuity). The value of the 9 subfield regions and the mean (SD) of the center point along with the operator's designation of normal or disease (options were AMD or ME associated with diabetic retinopathy or retinal vascular occlusion) were entered into an Access database (Microsoft, Redmond, Washington).
Because we have the same technician, the same machine, the same eye, and the same visit, we are assessing repeatability, not reproducibility (the closeness of agreement between independent results obtained with the same method on identical test material but under different conditions [eg, different operators, different apparatus, different laboratories, and/or after different intervals]). 2, 3 The coefficient of repeatability is 1.96 times the standard deviation of the difference of session 2 and session 1 measurements, a clinically important number because it tells the reader, based on this subset of submissions, how different 2 measurements must be before one can conclude that, with 95% probability, a change has occurred by natural history or by some intervention. Given the exploratory nature and multiple comparisons, only test statistics with PϽ.001 were considered statistically significant. Statistical analyses were performed using R 2 and SAS (SAS Institute Inc, Cary, North Carolina). Subgroups defined by the center point (CP) at session 1 were created arbitrarily to facilitate data presentation and evaluation ( Table 1 ). All of the scans with a CP of 325 µm or more were from diseased eyes; 95% of the scans with a CP of 175 µm or less were from normal eyes.
RESULTS

From
For the 139 normal scans, the mean (SD) CP was 173 (8) µm; for the 66 AMD scans, 383 (18) µm; and for the 76 ME scans, 399 (22) OCT3 retinal thickness tabular output note the fovea minimum parameter with a normal range of 135 to 215 µm; 11 of the normal eyes exceeded this range and 11 of the diseased eyes (6 AMD, 5 ME) were within this range.
For each of the 281 eyes, the session 1 CP vs session 2 CP was plotted ( Figure 1A ). As summarized in Table 2 , the CP coefficient of repeatability was 49 µm and the mean difference between session 1 and session 2 CP was 2 µm with a 95% confidence interval of −1 to 5 µm. There was no difference in the CP coefficient of repeatability between eyes with AMD and ME (data not shown). The CP coefficient of repeatability increased as the mean CP of the subgroup defined by the CP at session 1 increased. The average of session 1 CP and session 2 CP was plotted against the difference of session 1 minus session 2 ( Figure 1B) , and the CP coefficient of reliability for all 281 eyes and by subgroup are shown. The CP coefficient of reliability (17 µm) for the subgroup with a CP of 175 µm or less was different from the subgroup with a CP of 176 to 225 µm (28 µm) and that was different from the subgroup with a CP of 226 to 325 (57 µm) (PϽ.001).
For each of the 281 eyes, the session 1 CP vs the session 2 CP was plotted with a line segment whose length is 2 SDs and the midpoint is the CP (Figure 2) . As extreme examples, in Figure 2 , there is an eye with a session 1 CP of 441 µm (SD = 10 µm) and a session 2 CP of 286 µm (SD=115 µm) and there is another eye with a session 1 CP of 571 µm (SD = 20 µm) and a session 2 CP of 428 µm (SD= 167 µm). These 2 eyes and the 43 other eyes whose CP at session 1 was 426 µm or more had a CP coefficient of reliability of 78 µm and a mean difference of 12 µm with a 95% confidence interval of 0 to 24 including zero (Table 2) . Two subgroups were arbitrarily defined by the relationship of the standard deviation to the CP, 1 subgroup with more than 5% and the other, 5% or less (eg, for a CP of 150 µm, an SD of 7.5 µm or less). In the eyes with a CP of 426 µm or more, 80% (36 of 45 eyes) had a standard deviation of 5% or less of the CP. Comparison of these 2 subgroups did not show any difference in the CP reliability coefficient (47 µm vs 53 µm) ( Table 2 ). For the eyes with a CP of 175 µm or less, the subset of 62 eyes with a standard deviation of 5% or less of the CP differed in the CP reliability coefficient from the subset of 25 eyes with a standard deviation of more than 5% of the CP (CP reliability coefficients of 12 µm and 26 µm [P Ͻ.001]).
The CP is the measurement at the center of the fovea where radial scan lines intersect, in contrast to the center subfield, which is an average of the 128 sampled points encompassing a wider area rather than a single point. The center subfield coefficient of repeatability was 27 µm and the center subfield mean difference between session 1 and session 2 was 2 µm with a 95% confidence interval of −1 to 2 µm ( Table 3) . There was no difference in the center subfield coefficient of repeatability between eyes with AMD and ME (data not shown). The center subfield coefficient of repeatability for the subgroup with a CP of 175 µm or less (10 µm) was different from the subgroup with a CP of 176 to 225 µm (18 µm) (P Ͻ.001). For the subgroup with a CP of 175 µm or less, the subset of 62 eyes with a standard deviation of 5% or less of the CP did not differ in the center subfield repeatability coefficient from the subset of 25 eyes with a standard deviation of more than 5% of the CP (center subfield coefficients of reliability of 8 µm and 13 µm).
For each of the 281 eyes, the session 1 CP and center subfield were plotted (Figure 3) . These measurements were not independent. The estimate of how much larger the center subfield was than the CP was 57 µm for all 281 eyes and 75 µm for the subset with a CP of 325 µm or less. The solid line is the CP plus a constant (arbitrarily chosen as 25 µm), included as a common frame of reference in Figure 3 , and indicates that as the CP increases, the estimated line for the center subfield differs (largest visual discrepancy in the upper right portion of Figure 3 ).
For each of the retinal thickness subgroups, the macular map sectoral thickness diagram summarizes the session 1 mean (SD) CP, followed by the coefficient of repeatability and the 95% confidence interval on mean difference (session 1 CP minus session 2 CP) (Figures 4,  5, 6, 7, and 8) .
COMMENT
The numeric measurements generated by OCT scanning software are used by clinicians and researchers for detection and longitudinal assessment of macular thickening and for clinical research study eligibility and outcomes. However, the peer-reviewed literature provides relatively few data on the repeatability of such measurements. In contrast to fundus photography in the 1980s and 1990s, in recent years OCT has been in a more dynamic environment of evolving equipment and software.
Published reports of OCT3 reproducibility are limited by small samples and variable methods. In 1 study, 10 normal subjects had 1 eye imaged 6 times per day on 3 different occasions. 4 High reproducibility with the Fast Macular Thickness Map was reported, with an intraclass correlation of 88% and intervisit/intravisit standard deviations of less than 4 µm at the center subfield. In another study using OCT3, 10 normal subjects had 1 eye imaged twice by different operators on 3 separate occasions. 5 Analysis of variance demonstrated no difference in macular measurements. In 22 eyes with diabetic ME, repeated scanning with OCT3 yielded a reproducibility coefficient of 37 µm or less for the center subfield, which was considered good. 6 Studies of reproducibility of macular scanning with earlier-generation OCT WWW.ARCHOPHTHALMOL.COM 48 machines also are limited by small samples and variable methods, but with generally similar results. [7] [8] [9] Interoperator variability has been noted to be low in 2 studies of 10 9 and 25 patients, 10 whereas 1 study of 20 eyes suggested systematic difference based on macular thickness. 11 In a study using a single OCT3 machine and a single operator, Polito et al 12 report 9 µm as the coefficient of repeatability for the CP in healthy retinas (n=10; mean CP, 180 µm) and 20 µm, in eyes with clinical diabetic ME (n=15; mean CP, 394 µm). Given that these results are from not 1 but 134 different operators and not 1 but multiple clinical sites and that the patient groups were not directly comparable, it is not surprising that these coefficients of repeatability are larger (ie, 17 µm in the 87 eyes with a CP of 175 µm or less and 49 µm in all 281 eyes).
The results of the current study might be considered an ideal scenario to document repeatability of the OCT3 in a multicenter context; we examined replicate imaging studies, including diverse disease representation, a large number of trained and experienced OCT operators, and a situation whereby operators would be expected to submit only their highest-quality efforts (since these submissions would be used to determine certification for performance of OCT in clinical trials). 
